Monferini E - Search Results

1

Identification of a novel polymorphism in the fibronectin type II domain of the SEL1L gene and possible relation to the persistent hyperinsulinemic hypoglycemia of infancy.

Saltini G, Proverbio MC, Malferrari G, Biagiotti L, Boettcher P, Dominici R, Monferini E, Lorenzini E, Cattaneo M, Antonello D, Moore PS, Zamproni I, Viscardi M, Chiumello G, Biunno I. Saltini G, et al. Among authors: monferini e. Mutat Res. 2004 Oct 4;554(1-2):159-63. doi: 10.1016/j.mrfmmm.2004.04.007. Mutat Res. 2004. PMID: 15450414

2

Ctla4 and multiple sclerosis in the Italian population.

Malferrari G, Stella A, Monferini E, Saltini G, Proverbio MC, Grimaldi LM, Rossi-Bernardi L, Biunno I. Malferrari G, et al. Among authors: monferini e. Exp Mol Pathol. 2005 Feb;78(1):55-7. doi: 10.1016/j.yexmp.2004.10.001. Exp Mol Pathol. 2005. PMID: 15596061

3

RNA-mediated interference indicates that SEL1L plays a role in pancreatic beta-cell growth.

Diaferia G, Cattaneo M, Saltini G, Proverbio MC, Monferini E, Malferrari G, Albertini A, Biunno I. Diaferia G, et al. Among authors: monferini e. DNA Cell Biol. 2004 Aug;23(8):510-8. doi: 10.1089/1044549041562320. DNA Cell Biol. 2004. PMID: 15307954

4

High-quality genomic DNA from human whole blood and mononuclear cells.

Malferrari G, Monferini E, DeBlasio P, Diaferia G, Saltini G, Del Vecchio E, Rossi-Bernardi L, Biunno I. Malferrari G, et al. Among authors: monferini e. Biotechniques. 2002 Dec;33(6):1228-30. doi: 10.2144/02336bm09. Biotechniques. 2002. PMID: 12503304 Free article. No abstract available.

5

Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.

Arosio D, Manzoni L, Araldi EM, Caprini A, Monferini E, Scolastico C. Arosio D, et al. Among authors: monferini e. Bioconjug Chem. 2009 Aug 19;20(8):1611-7. doi: 10.1021/bc900155j. Epub 2009 Jul 22. Bioconjug Chem. 2009. PMID: 21141806

6

Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting.

Manzoni L, Belvisi L, Arosio D, Civera M, Pilkington-Miksa M, Potenza D, Caprini A, Araldi EM, Monferini E, Mancino M, Podestà F, Scolastico C. Manzoni L, et al. Among authors: monferini e. ChemMedChem. 2009 Apr;4(4):615-32. doi: 10.1002/cmdc.200800422. ChemMedChem. 2009. PMID: 19212960

7

Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.

Scandroglio A, Monferini E, Borsini F. Scandroglio A, et al. Among authors: monferini e. Pharmacol Res. 2001 Feb;43(2):179-83. doi: 10.1006/phrs.2000.0762. Pharmacol Res. 2001. PMID: 11243720

8

BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.

Volonté M, Monferini E, Cerutti M, Fodritto F, Borsini F. Volonté M, et al. Among authors: monferini e. J Neurochem. 1997 Jul;69(1):182-90. doi: 10.1046/j.1471-4159.1997.69010182.x. J Neurochem. 1997. PMID: 9202309 Free article.

9

BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex.

Borsini F, Giraldo E, Monferini E, Antonini G, Parenti M, Bietti G, Donetti A. Borsini F, et al. Among authors: monferini e. Naunyn Schmiedebergs Arch Pharmacol. 1995 Sep;352(3):276-82. doi: 10.1007/BF00168557. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 8584042

10

Medicinal chemistry of muscarinic agonists for the treatment of dementia disorders.

Cereda E, Brambilla A, Ezhaya A, Gaida W, Mendla K, Monferini E, Pitsikas N, Schiavi GB, Sagrada A. Cereda E, et al. Among authors: monferini e. Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):179-83. doi: 10.1007/BF03188919. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7867659

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters